1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of Global Market by Source 40
3.1 Market Overview by Source 40
3.2 Synthetic API 42
3.2.1 Branded Synthetic API 43
3.2.2 Generic Synthetic API 44
3.3 Semi-synthetic API 45
3.4 Natural Origin 46
4 Segmentation of Global Market by Type 47
4.1 Market Overview by Type 47
4.2 Standard API 49
4.3 High Potency API (HPAPI) 50
4.3.1 Branded HPAPI 51
4.3.2 Generic HPAPI 52
5 Segmentation of Global Market by Therapeutic Area 53
5.1 Market Overview by Therapeutic Area 53
5.2 Infectious Diseases 55
5.3 Oncology 56
5.4 Ophthalmology 57
5.5 Cardiovascular Disorders 58
5.6 Central Nervous System 59
5.7 Respiratory Disorders 60
5.8 Metabolic Diseases 61
5.9 Other Applications 62
6 Segmentation of Global Market by Application 63
6.1 Market Overview by Application 63
6.2 Clinical Use 65
6.3 Commercial Use 66
7 Segmentation of Global Market by Manufacturer Type 67
7.1 Market Overview by Manufacturer Type 67
7.2 Pharmaceutical Companies 69
7.3 CMOs 71
8 Segmentation of Global Market by Region 73
8.1 Geographic Market Overview 2020-2027 73
8.2 North America Market 2020-2027 by Country 77
8.2.1 Overview of North America Market 77
8.2.2 U.S. 80
8.2.3 Canada 84
8.2.4 Mexico 86
8.3 European Market 2020-2027 by Country 88
8.3.1 Overview of European Market 88
8.3.2 UK 91
8.3.3 France 93
8.3.4 Germany 95
8.3.5 Spain 97
8.3.6 Italy 99
8.3.7 Russia 101
8.3.8 Rest of European Market 103
8.4 Asia-Pacific Market 2020-2027 by Country 105
8.4.1 Overview of Asia-Pacific Market 105
8.4.2 China 108
8.4.3 Japan 110
8.4.4 India 113
8.4.5 Australia 115
8.4.6 South Korea 117
8.4.7 Rest of APAC Region 119
8.5 South America Market 2020-2027 by Country 121
8.5.1 Argentina 124
8.5.2 Brazil 126
8.5.3 Chile 128
8.5.4 Rest of South America Market 130
8.6 MEA Market 2020-2027 by Country 131
8.6.1 UAE 134
8.6.2 Saudi Arabia 136
8.6.3 South Africa 138
8.6.4 Other National Markets 140
9 Competitive Landscape 141
9.1 Overview of Key Vendors 141
9.2 New Product Launch, Partnership, Investment, and M&A 144
9.3 Company Profiles 145
Aurobindo Pharma Ltd. 145
Cambrex Corporation 147
Catalent, Inc. 148
Dr. Reddy's Laboratories Ltd. 149
GlaxoSmithKline plc 150
Lonza Group 151
Merck & Co., Inc. 152
Mylan N.V. 153
Novartis AG 154
Pfizer Inc. 155
Sun Pharmaceutical Industries Ltd. 156
Teva Pharmaceutical Industries Ltd. 157
Wuxi AppTec Co., Ltd. 158
10 Investing in Global Market: Risk Assessment and Management 159
10.1 Risk Evaluation of Global Market 159
10.2 Critical Success Factors (CSFs) 162
Related Reports and Products 165